Johnson & Johnson trades above 21x forward EPS with $24B in Q3 revenue, and a raised FY25 sales guidance outlook. Read why JNJ stock is downgraded to hold.

Johnson & Johnson has said it will lower the price of some medications sold to U.S. consumers, making it the latest ...

Nvidia and Eli Lilly unveiled a co-innovation AI Lab for drug discovery efforts. Nvidia announced a strategic collaboration ...

Investing.com - Futures linked to Canada’s main stock exchange pointed higher on Friday, as investors eyed a slight recovery ...

ImmunityBio, Inc. is upgraded to Buy reflecting improving Anktiva data & potential label expansions in NMIBC and NSCLC. Read ...

Industrial production climbed 0.8%, after a 2.0% jump in October, Germany's statistics agency Destatis said Friday, the first time output has increased for three consecutive months since 2022. A ...

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 months Notable responses were ...

AbbVie continues to project low single-digit growth through 2030 as it expands its immunology franchise and makes a major ...

Dick Zimmer was elected to the New Jersey Assembly in 1981 where he was the prime Assembly sponsor of New Jersey's first ...

Businesses of all sizes are wasting little time jumping into the world of artificial intelligence and using the technology as ...

JTA's proposed fare hikes for Connexion Plus, a service for disabled riders, are facing backlash over affordability concerns.

Over 70 percent of patients in the first-line subgroup responded to amivantamab plus chemotherapy with most responses lasting beyond 16 monthsNotable ...